Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID) (2020)
- Authors:
- USP affiliated authors: PAZIN FILHO, ANTONIO - FMRP ; MIRANDA, CARLOS HENRIQUE - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.thromres.2020.09.026
- Subjects: RESPIRAÇÃO ARTIFICIAL; ANTICOAGULANTES; TRANSTORNOS DA COAGULAÇÃO SANGUÍNEA; COVID-19
- Keywords: Mechanical ventilation; Anticoagulant treatment; D-dimer; Coagulopathy
- Language: Inglês
- Imprenta:
- Source:
- Título: Thrombosis Research
- ISSN: 0049-3848
- Volume/Número/Paginação/Ano: v. 196, p. 359-366, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: other-oa
-
ABNT
LEMOS, Anna Cristina Bertoldi et al. Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID). Thrombosis Research, v. 196, p. 359-366, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2020.09.026. Acesso em: 04 out. 2024. -
APA
Lemos, A. C. B., Espírito Santo, D. A. do, Salvetti, M. C., Gilio, R. N., Agra, L. B., Pazin Filho, A., & Miranda, C. H. (2020). Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID). Thrombosis Research, 196, 359-366. doi:10.1016/j.thromres.2020.09.026 -
NLM
Lemos ACB, Espírito Santo DA do, Salvetti MC, Gilio RN, Agra LB, Pazin Filho A, Miranda CH. Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID) [Internet]. Thrombosis Research. 2020 ; 196 359-366.[citado 2024 out. 04 ] Available from: https://doi.org/10.1016/j.thromres.2020.09.026 -
Vancouver
Lemos ACB, Espírito Santo DA do, Salvetti MC, Gilio RN, Agra LB, Pazin Filho A, Miranda CH. Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID) [Internet]. Thrombosis Research. 2020 ; 196 359-366.[citado 2024 out. 04 ] Available from: https://doi.org/10.1016/j.thromres.2020.09.026 - Evaluation of the performance of the modified early warning score in a Brazilian public hospital
- Anticoagulant interventions in hospitalized patients with COVID‐19: a scoping review of randomized controlled trials and call for international collaboration
- Clinical competence in ST-segment elevation myocardial infarction management by recently graduated physicians applying for a medical residency program
- In vivo demonstration of microvascular thrombosis in severe COVID-19
- Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil
- Estudo da associação entre desnervação simpática miocárdica e arritmias ventriculares graves em pacientes com cardiopatia chagásica crônica mediante emprego da cintilografia miocárdica com iodo-123 metaiodobenzilguanidina
- Therapeutic anticoagulation in COVID-19 patients [Carta]
- Recursos visuais
- Decreased alpha-1 glycoprotein acid related to mortality of septic patients in the emergency departament
- Risk factors and outcomes for patients with vascular disease and serious bleeding events
Informações sobre o DOI: 10.1016/j.thromres.2020.09.026 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003091087.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
